Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-09-01

FDA Approved: CLINDAMYCIN PHOSPHATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved a supplemental application for clindamycin phosphate by Sun Pharmaceutical Industries, Inc. This is for a generic antibiotic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLINDAMYCIN PHOSPHATE (Clindamycin phosphate)

Snippet

SUPPL AP for CLINDAMYCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE)